NLCP.OQXNewlake Capital Partners, INC

10-K: NewLake Capital Partners Reports Continued Growth in 2024, Navigates Evolving Cannabis Market

Sentiment:

Annual Results

📋All filings for Newlake Capital Partners, INC
🔒Login to Follow

NewLake Capital Partners' 2024 10-K filing reveals growth in rental income and strategic navigation of the evolving cannabis regulatory landscape, while addressing challenges with tenant performance.

Delay expectedThe hearing for the DEA to reschedule marijuana from Schedule I to Schedule III has been delayed at least 90 days due to a motion to remove the DEA from the hearings.
Capital raiseThe company has an At-The-Market (ATM) offering program in place, allowing it to offer and sell shares of its common stock having an aggregate offering amount of up to $50.0 million from time to time through a sales agent.The company may issue equity and debt securities at times when it believes that its stock price or cost of debt capital, respectively, is at a level that allows for the reinvestment of offering proceeds in accretive property acquisitions.The company may also issue common stock to permanently finance properties that were previously financed by debt securities.
Worse than expectedTwo tenants, Revolutionary Clinics and Calypso Enterprises, experienced financial challenges affecting rent payments, leading to partial rent payments and the use of escrow deposits.Revolutionary Clinics entered receivership in December 2024, raising concerns about its ability to continue as a going concern.The company recorded an impairment loss on warrants related to Revolutionary Clinics due to concerns about its ability to continue as a going concern.

Summary

  • NewLake Capital Partners, Inc., a REIT focused on the cannabis industry, filed its annual report on Form 10-K for the fiscal year ended December 31, 2024.
  • The company owns a geographically diversified portfolio of 32 properties across 12 states, leased to 13 tenants, comprising 17 dispensaries and 15 cultivation facilities.
  • Rental income increased to $48.9 million in 2024 from $46.3 million in 2023, driven by new acquisitions, improvement allowances, and annual escalations.
  • The company is actively managing risks related to tenant performance, with two tenants experiencing financial challenges affecting rent payments.
  • NewLake Capital Partners is monitoring and adapting to the evolving regulatory landscape, including potential rescheduling of cannabis under federal law.
  • The company had $102.6 million in liquidity as of December 31, 2024, including cash and availability under its Revolving Credit Facility.
  • The board of directors declared cash dividends totaling $1.70 per share of common stock during the year.
  • The company is focused on maintaining REIT qualification and managing its capital structure effectively.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While the company shows growth in revenue and maintains a strong liquidity position, there are concerns about tenant performance and the evolving regulatory landscape. The delay in the DEA hearing and the impairment loss on warrants contribute to a more cautious outlook.

Positives

  • The company experienced growth in rental income, driven by strategic acquisitions and improvement allowances.
  • The company maintains a geographically diversified portfolio across 12 states.
  • The company has a strong liquidity position with $102.6 million available.
  • The company continues to pay dividends to stockholders, demonstrating its commitment to returning value.
  • The company is actively monitoring and adapting to the evolving regulatory landscape, positioning itself for potential future opportunities.

Negatives

  • Two tenants, Revolutionary Clinics and Calypso Enterprises, experienced financial challenges affecting rent payments.
  • Revolutionary Clinics entered receivership in December 2024.
  • Calypso Enterprises did not pay contractual rent from September through December 2024, requiring the use of escrow deposits.
  • The company recorded an impairment loss on warrants related to Revolutionary Clinics due to concerns about its ability to continue as a going concern.

Risks

  • The company faces risks related to tenant performance and potential lease defaults.
  • The company is subject to the evolving regulatory landscape of the cannabis industry, including potential changes in federal and state laws.
  • The company faces competition for acquisitions of properties suitable for cannabis operations.
  • The company is subject to risks associated with real estate assets and the real estate industry, including economic downturns and changes in demand.
  • The company may have difficulty accessing the service of banks and other financial institutions, which may make it difficult to contract for real estate needs.

Future Outlook

The company expects that its cash flow from continuing operations over the next twelve months, combined with its cash reserves, will be sufficient to fund its business operations, pay cash dividends to its shareholders, make distributions on its OP Units, and cover debt service. Acquisitions and unfunded improvement allowance costs may require funding from borrowings, equity issuance and/or issuance of OP Units.

Management Comments

  • The company is focused on further creating a diversified portfolio based on tenants, geographical concentration and license concentration.
  • The company is active in the management of its portfolio to minimize risk and will work with tenants to identify opportunities to reposition assets to optimize long term value for shareholders.
  • The company evaluates the credit quality of its tenants and any guarantors on an ongoing basis.

Industry Context

The company operates in the fast-growing cannabis industry, which is expected to see legal cannabis sales in the U.S. reach $46 billion in 2028. The company believes it fills a need in an underserved market due to the misalignment of federal and state legislation regarding cannabis and the banking industry's general reluctance to finance owners of cannabis-related facilities.

Comparison to Industry Standards

  • Innovative Industrial Properties, Inc. (IIPR) is the largest publicly-traded cannabis-focused REIT and a major competitor.
  • NewLake competes with other companies with similar business models, independent investors, hedge funds, and cannabis operators themselves.
  • NewLake's focus on limited-license jurisdictions aims to capture rental income on properties with above-market property level cash flows and greater re-leasing probability.
  • The company believes its portfolio has a property rent coverage that is significantly greater than the average for the overall commercial real estate industry.

Legal Proceedings

  • As of December 31, 2024, the company was not a party to any material legal proceedings.

Stakeholder Impact

  • Shareholders may experience continued dividends, but also face risks related to tenant performance and regulatory changes.
  • Employees are subject to insider trading policies and may be affected by changes in company performance.
  • Tenants face potential regulatory challenges and economic pressures that could impact their ability to meet lease obligations.
  • Creditors face risks related to the company's ability to meet debt obligations if tenant performance declines.

Next Steps

  • The company will continue to monitor and adapt to the evolving regulatory landscape of the cannabis industry.
  • The company will work with tenants to identify opportunities to reposition assets to optimize long term value for shareholders.
  • The company will evaluate the credit quality of its tenants and any guarantors on an ongoing basis.
  • The company will continue to assess quarterly the collectability of lease payments for each tenant as required by ASC 842.

Key Dates

DateDescription
April 9, 2019NewLake Capital Partners, Inc. was formed.
December 31, 2019NewLake Capital Partners elected to be taxed as a REIT.
December 20, 2021Company entered into a $3.8 million loan payable to the seller of a cultivation facility in Chaffee, Missouri.
May 6, 2022NLCP Operating Partnership LP entered into a loan and security agreement for a $30.0 million Revolving Credit Facility.
July 29, 2022The Operating Partnership entered into an amendment to the Revolving Credit Facility, to increase the aggregate commitment under the Revolving Credit Facility from $30.0 million to $90.0 million.
November 7, 2022The board of directors authorized a stock repurchase program of up to $10.0 million of its common stock through December 31, 2023.
March 3, 2023The Company exercised its option to acquire an adjacent parcel of land to expand its cultivation facility in Missouri.
September 15, 2023The board of directors authorized an amendment to the stock repurchase program for the repurchase of up to an additional $10.0 million of outstanding common stock and extended the program through December 31, 2024.
October 27, 2023The Company closed on the sale of its property in Palmer, Massachusetts.
May 7, 2024The Company purchased a cultivation facility in Connecticut for approximately $4.0 million.
June 10, 2024The Company entered into an Equity Distribution Agreement (the EDA), relating to shares of its common stock, $0.01 par value per share, pursuant to an At The Market (ATM) offering program.
November 20, 2024The Company entered into another Equity Distribution Agreement (collectively the EDAs) related to its ATM program to add an additional sales agent.
December 13, 2024Revolutionary Clinics entered into receivership.
December 31, 2024End of the fiscal year.
March 6, 2025Date of the filing of the Annual Report on Form 10-K.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.